Abstract
Recent progress in the field of science and technology has catered us with new dimensions to understand the origin and complexity of biological events associated with the development of cancer. Growth of cancer is a multi-stage process which involves diverse genetic alterations and cellular signalling pathways, responsible for the development and maturation of tumours. Based on the recent advancement, several new strategies in cancer therapy are now available that offers better therapeutic results. However, there are a number of issues still existing which need to be addressed intensely to obtain effective results in cancer therapy thereby decreasing the mortality rate. Moreover, generation of resistant cancer cells after treatment with conventional methods is liable to depict an adverse scenario in cancer therapy, which demands new therapeutic and diagnostic modules in order to combat this fatal disease.
Abbreviations
- Ag NPs:
-
Silver nanoparticles
- Au NPs:
-
Gold nanoparticles
- Cl− :
-
Chloride ions
- Cu NPs:
-
Copper nanoparticles
- CuO:
-
Copper oxide
- DOX:
-
Doxorubicin
- ECM:
-
Extracellular matrix
- EPR:
-
Enhanced permeation and retention
- HCPT:
-
10-Hydroxycamptothecine
- LDH:
-
Lactate dehydrogenase
- MEC:
-
Minimum effective concentration
- MTs:
-
Metallothioneins
- NGS:
-
Next-generation sequencing
- NH2 :
-
Amine group
- NIR:
-
Near-infrared light
- NP:
-
Nanoparticles
- PD:
-
Paracetamol dimer
- PDT:
-
Photodynamic therapy
- PEG:
-
Polyethylene glycol (PEG)
- PS:
-
Photosensitizers
- PSMA:
-
Prostate-specific membrane antigen
- PTN:
-
Photothermalnanotherapeutics
- PTT:
-
Photothermal therapy
- PTX:
-
Paclitaxel
- PVP:
-
Polyvinylpyrrolidone
- QDs:
-
Quantum dots
- RES:
-
Reticuloendothelial system
- RNA:
-
Ribonucleic acid
- ROS:
-
Reactive oxygen species
- SERS:
-
Surface-enhanced Raman scattering
- SPR:
-
Surface plasmon resonance
- TiO2 :
-
Titanium oxide
- WHO:
-
World Health Organization
- ZnO:
-
Zinc oxide
References
Alkilany AM, Murphy CJ (2010) Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 12:2313–2333
American Cancer Society (2017) https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/photodynamic-therapy.html. Accessed 15 Aug 2017
Bañobre-López M, Teijeiro A, Rivas J (2013) Magnetic nanoparticle-based hyperthermia for cancer treatment. Rep Pract Oncol Radiother 18:397–400
Biener J, Wittstock A, Baumann TF, Weissmüller J, Bäumer M, Hamza AV (2009) Surface chemistry in nanoscale materials. Materials 2:2404–2428
Blackadar CB (2016) Historical review of the causes of cancer. World J Clin Oncol 7:54
Burgess DJ (2012) Therapy: enhancing efficacy by reducing side effects. Nat Rev Cancer 12:377
Cai Y, Shen H, Zhan J, Lin M, Dai L, Ren C, Shi Y, Liu J, Gao J, Yang Z (2017) Supramolecular “Trojan Horse” for nuclear delivery of dual anticancer drugs. J Am Chem Soc
Camp ER, Wang C, Little EC, Watson PM, Pirollo KF, Rait A, Cole DJ, Chang EH, Watson DK (2013) Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther 20:222–228
Cancer Institute NSW (2017) https://www.cancerinstitute.org.au/understanding-cancer/what-are-the-different-stages-of-cancer. Accessed 25 Feb 2017
Caracciolo G (2013) The protein corona effect for targeted drug delivery. Bioinspired Biomimetic and Nanobiomater 2:54–57
Casás-Selves M, DeGregori J (2011) How cancer shapes evolution and how evolution shapes cancer. Evol Educ Outreach 4:624–634
Chabner BA, Roberts TG (2005) Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 5:65–72
DeVita VT, Chu E (2008) A history of cancer chemotherapy. Can Res 68:8643–8653
Djurišić AB, Leung YH, Ng AMC, Xu XY, Lee PKH, Degger N, Wu RSS (2015) Toxicity of metal oxide nanoparticles: mechanisms, characterization, and avoiding experimental Artefacts. Small 11:26–44
Dostalova S, Cerna T, Hynek D, Koudelkova Z, Vaculovic T, Kopel P, Hrabeta J, Heger Z, Vaculovicova M, Eckschlager T, Stiborova M, Adam V (2016) Site-directed conjugation of antibodies to ApoferritinNanocarrier for targeted drug delivery to prostate cancer cells. ACS Appl Mater Interfaces 8:14430–14441
Fakruddin M, Hossain Z, Afroz H (2012) Prospects and applications of nanobiotechnology: a medical perspective. J Nanobiotechnol 10:31
Fass L (2008) Imaging and cancer: a review. Mol Oncol 2:115–152
Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–171
Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 7:5577–5591
Gliga AR, Skoglund S, OdnevallWallinder I, Fadeel B, Karlsson HL (2014) Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol. 11:11
Goymer P (2008) Natural selection: the evolution of cancer. Nature 454:1046–1048
Guisbiers G, Mejía-Rosales S, Leonard Deepak F (2012) Nanomaterial properties: size and shape dependencies. J Nanomater 2012:1–2
Hamzeh M, Sunahara GI (2013) In vitro cytotoxicity and genotoxicity studies of titanium dioxide (TiO2) nanoparticles in Chinese hamster lung fibroblast cells. Toxicol In Vitro 27:864–873
Harrison C (2013) Nanotechnology: biological proteins knock nanoparticles off target. Nat Rev Drug Discov 12:264
Iakovidis I, Delimaris I, Piperakis SM (2011) Copper and its complexes in medicine: a biochemical approach. Mol Biol Int 2011:1–13
Ivask A, Titma T, Visnapuu M, Vija H, Kakinen A, Sihtmae M, Pokhrel S, Madler L, Heinlaan M, Kisand V, Shimmo R, Kahru A (2015) Toxicity of 11 metal oxide nanoparticles to three mammalian cell types in vitro. Curr Top Med Chem 15:1914–1929
Jain K (2009) Role of nanobiotechnology in the development of personalized medicine. Nanomedicine 4:249–252
Kayl AE, Meyers CA (2006) Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol 18:24–28
Khandelia R, Jaiswal A, Ghosh SS, Chattopadhyay A (2013) Gold nanoparticle-protein agglomerates as versatile nanocarriers for drug delivery. Small 9:3494–3505
Kim JA, Åberg C, Salvati A, Dawson KA (2011) Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol 7:62–68
Komarova NL, Boland CR (2013) Cancer: calculated treatment. Nature 499:291–292
Liao L, Liu J, Dreaden EC, Morton SW, Shopsowitz KE, Hammond PT, Johnson JA (2014) A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin. J Am Chem Soc 136:5896–5899
Liu PF, Liu D, Cai C, Chen X, Zhou Y, Wu L, Sun Y, Dai H, Kong X, Xie Y (2016) Size-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cells. Int J Nanomed 11:3557–3570
Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5:845–856
Marchant G (2009) Small is beautiful: what can nanotechnology do for personalized medicine? Curr Pharmacogenomics Personalized Med 7:231–237. doi:10.2174/187569209790112346
Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449–458
Mehta D, Guvva S, Patil M (2008) Future impact of nanotechnology on medicine and dentistry. J Indian Soc Periodontol 12:34
Miyoshi N, Kundu SK, Tuziuti T, Yasui K, Shimada I, Ito Y (2016) Combination of sonodynamic and photodynamic therapy against cancer would be effective through using a regulated size of nanoparticles. Nanosci Nanoeng 4:1–11
Nagy JA, Chang S-H, Dvorak AM, Dvorak HF (2009) Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 100:865–869
Narayana A (2014) Applications of nanotechnology in cancer: a literature review of imaging and treatment. J Nucl Med Radiat Ther 5:195
National Cancer Institute (2015) https://www.cancer.gov/about-cancer/diagnosis-staging/staging. Accessed 25 Feb 2017
Neagu M, Piperigkou Z, Karamanou K, Engin AB, Docea AO, Constantin C, Negrei C, Nikitovic D, Tsatsakis A (2017) Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol 91:1031–1048
Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941–1949
Paszko E, Ehrhardt C, Senge MO, Kelleher DP, Reynolds JV (2011) Nanodrug applications in photodynamic therapy. Photodiagn Photodyn Ther 8:14–29
Patel P, Kansara K, Senapati VA, Shanker R, Dhawan A, Kumar A (2016) Cell cycle dependent cellular uptake of zinc oxide nanoparticles in human epidermal cells. Mutagenesis 31:481–490
Périgo EA, Hemery G, Sandre O, Ortega D, Garaio E, Plazaola F, Teran FJ (2015) Fundamentals and advances in magnetic hyperthermia. Appl Phys Rev 2:041302
Prabhu BM, Ali SF, Murdock RC, Hussain SM, Srivatsan M (2010) Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat. Nanotoxicology 4:150–160
Rosenblum D, Peer D (2014) Omics-based nanomedicine: the future of personalized oncology. Cancer Lett 352:126–136
Sahoo AK, Goswami U, Dutta D, Banerjee S, Chattopadhyay A, Ghosh SS (2016) Silver nanocluster embedded composite nanoparticles for targeted prodrug delivery in cancer theranostics. ACS Biomater Sci Eng 2:1395–1402
Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12:278–287
Soares T, Ribeiro D, Proença C, Chisté RC, Fernandes E, Freitas M (2016) Size-dependent cytotoxicity of silver nanoparticles in human neutrophils assessed by multiple analytical approaches. Life Sci 145:247–254
Soenen SJ, Manshian B, Montenegro JM, Amin F, Meermann B, Thiron T, Cornelissen M, Vanhaecke F, Doak S, Parak WJ, De Smedt S, Braeckmans K (2012) Cytotoxic effects of gold nanoparticles: a multiparametric study. ACS Nano 6:5767–5783
Stellacci F (2005) Nanoscale materials: a new season. Nat Mater 4:113–114
Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458:719–724
Tang W, Zhen Z, Wang M, Wang H, Chuang Y-J, Zhang W, Wang GD, Todd T, Cowger T, Chen H, Liu L, Li Z, Xie J (2016) Red blood cell-facilitated photodynamic therapy for cancer treatment. Adv Func Mater 26:1757–1768
Thariat J, Hannoun-Levi J-M, Sun Myint A, Vuong T, Gérard J-P (2012) Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clini Oncol 10:52–60
Tortorella S, Karagiannis TC (2014) Transferrin receptor-mediated endocytosis: a useful target for cancer therapy. J Membr Biol 247:291–307
Vega D, Lodge P, Vivero-Escoto J (2015) Redox-responsive porphyrin-based polysilsesquioxane nanoparticles for photodynamic therapy of cancer cells. Int J Mol Sci 17:56
Wang S, Low PS (1998) Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J Control Release 53:39–48
Wongrakpanich A, Mudunkotuwa IA, Geary SM, Morris AS, Mapuskar KA, Spitz DR, Grassian VH, Salem AK (2016) Size-dependent cytotoxicity of copper oxide nanoparticles in lung epithelial cells. Environ Sci Nano 3:365–374
Yang S-T, Liu J-H, Wang J, Yuan Y, Cao A, Wang H, Liu Y, Zhao Y (2010) Cytotoxicity of zinc oxide nanoparticles: importance of microenvironment. J Nanosci Nanotechnol 10:8638–8645
Zhang D, Wang (2012) Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholicacid-O-carboxymethylatedchitosan–folic acid micelles. Int J Nanomed 7:325–337
Zou L, Wang H, He B, Zeng L, Tan T, Cao H, He X, Zhang Z, Guo S, Li Y (2016) Current approaches of photothermal therapy in treating cancer metastasis with nanotherapeutics. Theranostics 6:762–772
Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L (2016) Current challenges in cancer treatment. Clin Ther 38:1551–1566
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Sahoo, A.K., Verma, A., Pant, P. (2017). Nanoformulations for Cancer Therapy. In: Rai, M., Alves dos Santos, C. (eds) Nanotechnology Applied To Pharmaceutical Technology. Springer, Cham. https://doi.org/10.1007/978-3-319-70299-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-70299-5_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70298-8
Online ISBN: 978-3-319-70299-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)